Tak-228
Refractory Pancreatic Neuroendocrine Carcinoma
National Cancer Institute (NCI)Phase 2
—
Rating in progress
Tak-228 in Refractory Pancreatic Neuroendocrine Carcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant